About Szpital Wojewodzki ( Site 1062)
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Szpital Wojewodzki ( Site 1062)
During the past decade, Szpital Wojewodzki ( Site 1062) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of First-line Pembrolizumab (MK-3475) With Lenvatinib (MK-7902/E7080) in Urothelial Carcinoma Cisplatin-ineligible Participants Whose Tumors Express Programmed Cell Death-Ligand 1 and in Participants Ineligible for Platinum-containing Chemotherapy (MK-7902-011/E7080-G000-317/ LEAP-011)
2019-05-06
2023-10-31
Active, not recruiting
487
Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus Enfortumab Vedotin Plus Cystectomy Versus Cystectomy Alone in Participants Who Are Cisplatin-ineligible or Decline Cisplatin With Muscle-invasive Bladder Cancer (MK-3475-905/KEYNOTE-905/EV-303)
2019-07-24
2027-12-15
Recruiting
857
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Szpital Wojewodzki ( Site 1062)"
#1 collaborator was "Astellas Pharma Global Development, Inc." with 1 trials as a collaborator, "Eisai Inc." with 1 trials as a collaborator and "Seagen Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Szpital Wojewodzki ( Site 1062)
According to Clinical.Site data, the most researched conditions in "Szpital Wojewodzki ( Site 1062)" are
"Urinary Bladder Cancer, Muscle-invasive" (1 trials) and "Urothelial Carcinoma" (1 trials). Many other conditions were trialed in "Szpital Wojewodzki ( Site 1062)" in a lesser frequency.
Clinical Trials Intervention Types at Szpital Wojewodzki ( Site 1062)
Most popular intervention types in "Szpital Wojewodzki ( Site 1062)" are "Drug" (2 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Pembrolizumab" (2 trials), "Enfortumab Vedotin" (1 trials), "Lenvatinib" (1 trials), "Placebo for lenvatinib" (1 trials) and "Surgery (radical cystectomy (RC) plus Pelvic Lymph Node Dissection [PLND])" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Szpital Wojewodzki ( Site 1062)
The vast majority of trials in "Szpital Wojewodzki ( Site 1062)" are
2 trials for "All" genders.
Clinical Trials Status at Szpital Wojewodzki ( Site 1062)
Currently, there are NaN active trials in "Szpital Wojewodzki ( Site 1062)".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Szpital Wojewodzki ( Site 1062),
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Szpital Wojewodzki ( Site 1062), 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".